Letter to the Editor the risk of incomplete ablation due to the heat-sink effect as well as the risk of TIPS membrane destruction and thus potentially occluding the stent lumen." We would like to refer the authors and the readers to the article published by our group entitled "Transjugular Intrahepatic Portosystemic Shunt Occlusion via Modified Pringle Maneuver for Radiofrequency Ablation of Nearby Tumor" (2) , in which in the exact same situation, temporary occlusion of the TIPS by inflating a non-compliant balloon was used to avert the development of a heat-sink during active ablation using RFA and the same access was used to measure shunt pressure and determine the integrity of the shunt after ablation. This technique has since been coined the "modified Pringle maneuver" and has been accepted within the ablation community. In our case, the TIPS remains patent and there has been no local tumor recurrence as of today (3 years since the procedure), demonstrating both the safety and feasibility of this technique.
Of note, while IRE is a novel ablation technique that is likely to present as a potential improvement to the current status of tumor ablation, its exact role in the treatment of HCC has yet to be validated, and the technology is currently not widely available. As such, readers should be aware that an HCC adjacent to a TIPS should not be considered a contraindication for curative ablation using conventional techniques such as RFA or microwave ablation. Additionally, the added advantage of accessing the TIPS for the modified Pringle maneuver, is that the shunt function could be assessed immediately after ablation and any potential dysfunction be remedied without delay (e.g., re-stenting), and this should be a consideration whenever potential shunt damage from any ablative therapy is anticipated. The aim of our case report was not to depict tumor lesions surrounding a transjugular intrahepatic portosystemic shunt stent graft as a contraindication for thermal ablation. Of course, we agree with Dr. Pua that the "modified Pringle Maneuver" with temporary shunt occlusion via inflating a non-compliant balloon represents an alternative method for safe and effective tumor treatment in such areas when using thermal ablation, but in our opinion, the percutaneous placement of three 19-gauge electrodes for irreversible electroporation alone without the need of an additional and technically challenging angiographic intervention represents an easier method of effective tumor treatment, although we are, of course, aware that IRE is a novel technology with limited availability.
As already mentioned in our case study, we also agree that there is a strong need for prospective studies for evaluation of the long-term efficacy of irreversible electroporation.
